There is hope in the fight against Covid-19. New evidence now exist in the United States of America supporting this procedure. Physicians in the Kansas City area, including Joe Brewer, Dan Hinthorn and Dr. Jeff Colyer, continue to see a lot of patients and some have shown progress. Hydroxychloroquine has been applied to treatment options by major medical facilities including the University of Washington and Mass General.
In addition, before this, according to a study conducted by French researchers on 80 cases who recovered from the virus within six days of treatment, a combination of hydroxychloroquine and azithromycin has been found effective in treating patients with the COVID-19 coronavirus.
Hydroxychloroquine is an anti-malarial and anti-inflammatory medication used to treat autoimmune conditions such as lupus and rheumatoid arthritis, although it has been tested against symptoms of the novel coronavirus with some results.
Bahrain is one of the first countries to study hydroxychloroquine as a COVID-19 medication, having first used the drug on 26 February, two days after the first case of coronavirus was reported.
Countries around the world are increasing access to hydroxychloroquine and chloroquine, similar compounds that are synthetic versions of quinine, which derive from cinchona trees and have been used to treat malaria for decades.
Considering the urgent therapeutic need to control this disease with efficient and safe medicines, and considering the negligible cost of both hydroxychloroquine and azithromycin, we believe that this therapeutic approach should be tested urgently by medical practitioners both to prevent the spread of the disease and to treat patients until serious irreversible respiratory complications.
Even now, medical experts are still questioning the use of chloroquine as a drug. Usage of chloroquine for symptomatic treatment of coronavirus has not been licensed by the World Health Organisation. The U.S. Food and Drug Administration (FDA) is currently researching a way to make the drug available for emergency use in the United States, but in a way that gives the government data about whether it is safe and effective.
